Robert D'Amato
53Patents
20h-index
22Co-inventors
88Inventor score
Filing activity: Nov 19, 1980 → Feb 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5712291A | Methods and compositions for inhibition of angiogenesis | Human Necessities | 222 | Expired |
| US5629327A | Methods and compositions for inhibition of angiogenesis | Human Necessities | 186 | Expired |
| US5593990A | Methods and compositions for inhibition of angiogenesis | Human Necessities | 153 | Expired |
| US6071948A | Methods and compositions for inhibition of angiogenesis | Human Necessities | 115 | Expired |
| US5504074A | Estrogenic compounds as anti-angiogenic agents | Chemistry; Metallurgy | 112 | Expired |
| US6518298B2 | Methods and compositions for inhibition of angiogenesis with EM-138 | Human Necessities | 91 | Expired |
| US6235756A | Methods and compositions for inhibition of angiogenesis by thalidomide | Human Necessities | 90 | Expired |
| US6469045B1 | Methods and compositions for inhibition of angiogenesis with EM-138 | Human Necessities | 89 | Expired |
| US6114355A | Methods and compositions for inhibition of angiogenesis | Human Necessities | 88 | Expired |
| US6420414B1 | Amino derivatives of EM-138 and methods of treating angiogenesis with same | Human Necessities | 86 | Expired |
| US6228879A | Methods and compositions for inhibition of angiogenesis | Human Necessities | 64 | Expired |
| US7435745B2 | Methods and compositions for inhibition of angiogenesis | Human Necessities | 55 | Expired |
| US6017949A | Method of regulating the female reproductive system through angiogenesis inhibitors | Human Necessities | 53 | Expired |
| US5892069A | Estrogenic compounds as anti-mitotic agents | Chemistry; Metallurgy | 42 | Expired |
| US7524865B2 | Methods and compositions for treating an ocular neovascular disease | Human Necessities | 41 | Expired |
| US5661143A | Estrogenic compounds as anti-mitotic agents | Chemistry; Metallurgy | 40 | Expired |
| US6528676B1 | Estrogenic compounds as anti-mitotic agents | Chemistry; Metallurgy | 30 | Expired |
| US8143283B1 | Methods for treating blood-born tumors with thalidomide | Human Necessities | 28 | Expired |
| US9751655B2 | Vessel with folded dam | Performing Operations; Transporting | 27 | Active |
| US7112602B2 | Methods of treating undesired angiogenesis with 2-methyl-EM-138 | Chemistry; Metallurgy | 24 | Expired |
| US6930128B2 | Estrogenic compounds as anti-mitotic agents | Chemistry; Metallurgy | 19 | Expired |
| US7153867B2 | Use of nitrogen substituted thalidomide analogs for the treatment of macular degenerator | Human Necessities | 16 | Expired |
| US6723858B2 | Estrogenic compounds as anti-mitotic agents | Chemistry; Metallurgy | 15 | Expired |
| US8039488B2 | Methods and compositions for inhibition of angiogenesis | Human Necessities | 15 | Active |
| US6908910B2 | Estrogenic compounds as anti-mitotic agents | Chemistry; Metallurgy | 9 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.